The use of streptokinase-streptodornase in the treatment of postneumonic empyema
- PMID: 14814722
Item in Clipboard
The use of streptokinase-streptodornase in the treatment of postneumonic empyema
J Thorac Surg.
1951 Mar.
No abstract available
Similar articles
-
[Treatment of pleural empyema with streptokinase and streptodornase].Pediatr Pol. 1955 Dec;30(12):1145-52. Pediatr Pol. 1955. PMID: 13310068 Polish. No abstract available.
-
[Streptokinase-streptodornase. III. Its use in empyema].Med Panam. 1956 Sep;7(3):191-4. Med Panam. 1956. PMID: 13377897 Spanish. No abstract available.
-
The use of streptokinase-streptodornase in the treatment of chronic empyema; with an interpretive discussion of enzymatic actions in the field of intrathoracic diseases.J Thorac Surg. 1951 Apr;21(4):325-41. J Thorac Surg. 1951. PMID: 14825490 No abstract available.
-
[THERAPY OF THROMBOEMBOLISM. 2].Med Klin. 1963 Nov 15;58:1869-72. Med Klin. 1963. PMID: 14111019 Review. German. No abstract available.
-
[CARDIOLOGY].Gaz Med Fr. 1963 Dec 25;70:3799-804. Gaz Med Fr. 1963. PMID: 14099949 Review. French. No abstract available.
Cited by
-
Intrapleural streptokinase in the management of empyema.Thorax. 1994 Sep;49(9):856-9. doi: 10.1136/thx.49.9.856. Thorax. 1994. PMID: 7940421 Free PMC article.
-
A Comparative Study of the Safety and Efficacy of Intrapleural Fibrinolysis With Streptokinase and Urokinase in the Management of Loculated Pleural Effusions.Cureus. 2022 Jun 24;14(6):e26271. doi: 10.7759/cureus.26271. eCollection 2022 Jun. Cureus. 2022. PMID: 35898352 Free PMC article.
-
Staphylococcal pneumonia: a review of 329 cases.Can Med Assoc J. 1960 Mar 5;82(10):513-7. Can Med Assoc J. 1960. PMID: 14436744 Free PMC article. No abstract available.
-
Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD002312. doi: 10.1002/14651858.CD002312.pub4. Cochrane Database Syst Rev. 2019. PMID: 31684683 Free PMC article.
-
Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper.Open Heart. 2018 Feb 26;5(1):e000735. doi: 10.1136/openhrt-2017-000735. eCollection 2018. Open Heart. 2018. PMID: 29531763 Free PMC article. Review.